Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-021166

Director sold 5,000 shares at $15.41 ($77,050)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CHESS ROBERT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-03-14 Exercise or conversion : show line 1 in the form +5,000 $8.37 $41,850 276,623 D
2017-03-14 Sale : show line 2 in the form −5,000 $15.41 $77,050 271,623 D
Open-market sales · 5,000 sh · avg $15.41 · $77,050

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-03-14 Exercise or conversion : show line 3 in the form Stock Option −5,000 $8.37 2017-09-14 5,000 10,000 D
Loading xslF345X03/doc4.xml…